ClinVar Miner

Submissions for variant NM_000249.4(MLH1):c.2152C>T (p.His718Tyr)

gnomAD frequency: 0.02345  dbSNP: rs2020873
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 29
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
International Society for Gastrointestinal Hereditary Tumours (InSiGHT) RCV000030220 SCV000106553 no known pathogenicity Lynch syndrome 2013-09-05 reviewed by expert panel research MAF >1%
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000035352 SCV000059000 benign not specified 2011-12-14 criteria provided, single submitter clinical testing The His718Tyr variant (rs2020873) in MLH1 is present in various populations at f requencies ranging from ~1% to ~16% and is more common individuals with African ancestry. In addition, this variant was reported in patient and control chromoso mes with equal frequncy (Barnetson 2008, Moussa 2011, Weber 1999). Finally, func tional studies have shown the His718Tyr has no discernbile impact on the functio n of the MMR complex (Martinez 2010, Kondo 2003). Therefore this variant is beni gn and not expected to have clinical significance.
Eurofins Ntd Llc (ga) RCV000035352 SCV000110266 benign not specified 2013-09-10 criteria provided, single submitter clinical testing
Invitae RCV001081091 SCV000153886 benign Hereditary nonpolyposis colorectal neoplasms 2024-02-01 criteria provided, single submitter clinical testing
GeneDx RCV000035352 SCV000170301 benign not specified 2013-10-18 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Ambry Genetics RCV000157759 SCV000212715 benign Hereditary cancer-predisposing syndrome 2014-11-18 criteria provided, single submitter clinical testing This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia RCV000030220 SCV000257652 likely benign Lynch syndrome 2015-02-05 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV000035352 SCV000303149 benign not specified criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000625495 SCV000443341 likely benign Colorectal cancer, hereditary nonpolyposis, type 2 2018-01-23 criteria provided, single submitter clinical testing This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign.
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV000035352 SCV000604233 benign not specified 2018-08-29 criteria provided, single submitter clinical testing
Color Diagnostics, LLC DBA Color Health RCV000157759 SCV000684802 benign Hereditary cancer-predisposing syndrome 2022-01-01 criteria provided, single submitter clinical testing
Genome Diagnostics Laboratory, Amsterdam University Medical Center RCV000625495 SCV000745683 benign Colorectal cancer, hereditary nonpolyposis, type 2 2016-11-11 criteria provided, single submitter clinical testing
Center for Human Genetics, Inc, Center for Human Genetics, Inc RCV000625495 SCV000781765 uncertain significance Colorectal cancer, hereditary nonpolyposis, type 2 2016-11-01 criteria provided, single submitter clinical testing
Sema4, Sema4 RCV000157759 SCV002528721 benign Hereditary cancer-predisposing syndrome 2020-01-30 criteria provided, single submitter curation
Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital RCV000035352 SCV002550521 benign not specified 2023-08-15 criteria provided, single submitter clinical testing
Institute for Biomarker Research, Medical Diagnostic Laboratories, L.L.C. RCV000157759 SCV002819149 benign Hereditary cancer-predisposing syndrome 2022-12-20 criteria provided, single submitter clinical testing
CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario RCV003149581 SCV003838873 benign Breast and/or ovarian cancer 2021-10-29 criteria provided, single submitter clinical testing
KCCC/NGS Laboratory, Kuwait Cancer Control Center RCV000625495 SCV004015877 benign Colorectal cancer, hereditary nonpolyposis, type 2 2023-07-07 criteria provided, single submitter clinical testing
All of Us Research Program, National Institutes of Health RCV000030220 SCV004843287 benign Lynch syndrome 2024-02-05 criteria provided, single submitter clinical testing
Biesecker Lab/Clinical Genomics Section, National Institutes of Health RCV000034546 SCV000043331 no known pathogenicity not provided 2012-07-13 no assertion criteria provided research Converted during submission to Benign.
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000030220 SCV000052887 benign Lynch syndrome 2011-10-26 no assertion criteria provided clinical testing
ITMI RCV000035352 SCV000085547 not provided not specified 2013-09-19 no assertion provided reference population
Pathway Genomics RCV000144604 SCV000189931 benign Lynch syndrome 1 2014-07-24 no assertion criteria provided clinical testing
Mayo Clinic Laboratories, Mayo Clinic RCV000035352 SCV000257088 likely benign not specified no assertion criteria provided clinical testing
Department of Pathology and Laboratory Medicine, Sinai Health System RCV001353518 SCV000592442 likely benign Carcinoma of colon no assertion criteria provided clinical testing The MLH1 p.His718Tyr variant was identified in 6 of 2626 proband chromosomes (frequency: 0.002) from individuals with sporadic colorectal cancer or suspected HNPCC, none of whom met complete requirements of the Amsterdam or Bethesda criteria (Kim 2004, Kondo 2003, Takahashi 2007, Moussa 2011, Schafmayer 2007). This variant was also identified in 17 of 2254 control chromosomes from the above studies (frequency: 0.008), in the 1000 Genomes Project with a frequency of 0.028, and in the Exome Variant Server ESP Project with a frequency of 0.07 amongst African American alleles, suggesting that this variant may represent a benign polymorphism in certain populations. The variant was also reported in dbSNP (rs2020873) and LOVD. In vitro MMR assays and yeast hybrid-two assays examining the ability of the variant to repair a heteroduplex DNA with mismatch bases found that its activity was similar to that of wildtype (Kondo 2003, Takahashi 2007), suggesting that this is a nonpathogenic alteration. The p.His718 residue is conserved across mammals and computational analyses (PolyPhen, SIFT, AlignGVGD) suggest that the p.His718Tyr variant may impact the protein. However, this information is not predictive enough to assume pathogenicity. In summary, based on the above information, we cannot determine the clinical significance of this variant with certainty at this time, although we would lean towards a more benign role for this variant. In summary, this variant is classified as predicted benign.
True Health Diagnostics RCV000157759 SCV000788023 benign Hereditary cancer-predisposing syndrome 2017-10-26 no assertion criteria provided clinical testing
Clinical Genetics, Academic Medical Center RCV000035352 SCV001922338 benign not specified no assertion criteria provided clinical testing
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ RCV000035352 SCV001958947 benign not specified no assertion criteria provided clinical testing
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) RCV000035352 SCV002036958 benign not specified no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.